Á lódáil...
New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection
Chronic hepatitis B (CHB) affects over 350 million individuals worldwide and is the most common cause of liver cancer. In the United States, CHB affects at least 2 to 3 million individuals, and current therapies can control the disease but not cure it. There are over 30 new molecules being studied i...
Na minha lista:
| Foilsithe in: | Gastroenterol Hepatol (N Y) |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Millennium Medical Publishing
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5495044/ https://ncbi.nlm.nih.gov/pubmed/28690451 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|